North America Arterial Blood Gas Kits Market Forecast to 2031 - Regional Analysis - by Syringe Type, Type, Usage, Application, Needle Gauge, Syringe Volume, and End User

Description

List of Tables

The North America arterial blood gas kits market was valued at US$ 3,01,799.63 thousand in 2023 and is expected to reach US$ 5,34,661.28 thousand by 2031; it is estimated to register a CAGR of 7.4% from 2023 to 2031.

Increasing Incidence of Respiratory Diseases Fuels North America Arterial Blood Gas Kits Market

Respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pneumonia lead to a huge burden on public healthcare systems in various countries across the world. Infections, smoking, and genetic factors can cause serious respiratory complications. Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death globally, resulting in 3.5 million deaths in 2021, which represents about 5% of all deaths worldwide. Approximately 90% of COPD-related deaths among individuals under 70 years of age occur in low- and middle-income countries (LMIC). In 2021, the American Lung Association ranked COPD third among the leading causes of death in the US, and over 16.4 million people are diagnosed with the condition that year. As per the Asthma and Allergy Foundation of America, ~26 million people in the US had asthma in 2022. The United Nations International Children's Emergency Fund (UNICEF) stated that nearly 1,400 per 100,000 children, i.e., 1 case per 71 children, are diagnosed with pneumonia every year. Breathing issues and oxygen shortages are common in patients suffering from respiratory disorders. Arterial blood gas (ABG) tests are performed to measure oxygen and carbon dioxide gases dissolved in blood. The test serves as a basis of care delivered to patients suffering from acute and chronic respiratory disease. Thus, the surging incidence of acute and chronic respiratory diseases propels the demand for arterial blood gas test kits.

North America Arterial Blood Gas Kits Market Overview

According to the HF Stats (SM) initiative launched by the Heart Failure Society of America (HFSA) in 2023, 1 in 4 individuals (~25%) are expected to experience HF in their lifetime, a rise from the previous estimate of 1 in 5 individuals (~20%). As per HF Stats, an HFSA database, ~6.7 million Americans over 20 years of age suffer HF, and the prevalence is expected to rise to 8.5 million Americans by 2030. The lifetime risk of HF has increased to 24%, i.e., ~1 in every 4 individuals is projected to suffer from HF in their lifetime. According to the Asthma and Allergy Foundation of America, ~26 million people in the US had asthma in 2022, one of the world's most common respiratory diseases. Respiratory infections cause more severe disease, leading to hospitalizations or death. Mortality is more common in older persons than in younger ones due to age-related issues such as frailty and immunosenescence. Asthma is one of the most common respiratory diseases among senior citizens. According to the 2020 Census, the geriatric population reached 55.8 million (16.8%) of the total US population in 2020, and it is projected to rise significantly during 2012-2050. These individuals need a greater understanding of the impact of respiratory diseases on their health, as patients suffering from respiratory disorders usually experience breathing issues due to oxygen shortage. Arterial blood gas analysis evaluates dissolved oxygen and carbon dioxide content, in the form of partial oxygen pressures (PaO2) and partial carbon dioxide pressures (PaCO2), in the arterial blood of patients. PaCO2 gives information on ventilation status (acute or chronic respiratory failure), while PaO2 provides insights into oxygenation status. The growing prevalence of chronic diseases necessitating arterial blood gas analysis, including respiratory failure, acute respiratory distress syndrome (ARDS), asthma, diabetic ketoacidosis, renal tubular acidosis, heart failure (HF), and congenital metabolic diseases, is the major factor contributing to the largest share of the US in the arterial blood gas kits market. Moreover, the country's well-established position in terms of technological advancements contributes notably to the availability of various arterial blood gas kits and associated technologies.

North America Arterial Blood Gas Kits Market Revenue and Forecast to 2031 (US$ Thousand)

North America Arterial Blood Gas Kits Market Segmentation

The North America arterial blood gas kits market is categorized into syringe type, type, usage, application, needle gauge, syringe volume, end user, and country.

Based on syringe type, the North America arterial blood gas kits market is bifurcated into luer slip syringe and luer lock syringe. The luer lock syringe segment held a larger market share in 2023.

In terms of type, the North America arterial blood gas kits market is bifurcated into vented and non-vented. The vented segment held a larger market share in 2023.

By usage, the North America arterial blood gas kits market is bifurcated into pre-set plunger mode and manual aspiration. The pre-set plunger mode segment held a larger market share in 2023.

Based on application, the North America arterial blood gas kits market is bifurcated into in vitro diagnostics and electrolyte analysis. The in vitro diagnostics segment held a larger market share in 2023. Furthermore, the in vitro diagnostics segment is sub segmented into pH blood gas, oxygen content, and others.

In terms of needle gauge, the North America arterial blood gas kits market is segmented into less than 23G, 23G to 25G, and greater than 25G. The 23G to 25G segment held the largest market share in 2023.

Based on syringe volume, the North America arterial blood gas kits market is segmented into 1ml, 3ml, and others. The 3ml segment held the largest market share in 2023.

By end user, the North America arterial blood gas kits market is categorized into hospitals & clinics, diagnostic laboratories, and others. The hospitals & clinics held the largest market share in 2023.

Based on country, the North America arterial blood gas kits market is segmented into the US, Canada, and Mexico. The US dominated the North America arterial blood gas kits market share in 2023.

Radiometer Medical ApS, Vyaire Medical Inc, Opti Medical Systems, Siemens Healthineers AG, AdvaCare Pharma USA LLC, Becton Dickinson and Co, ICU Medical Inc, SunMed Group Holdings LLC (AirLife), Trudell Healthcare Solutions Inc, SARSTEDT AG & Co KG, and Lepu Medical Technology Beijing Co Ltd. are among the leading companies operating in the North America arterial blood gas kits market.

Product Code: TIPRE00024505

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. North America Arterial Blood Gas Kits Market Landscape

4.1 PEST Analysis
4.2 Pricing Analysis
4.3 Patient Portfolio
4.4 Pre and Post COVID 19 Market Scenario
4.5 Domestic vs Branded ABG Syringes Manufacturing in Developing Countries
4.6 Venous Gas Analysers vs Arterial Blood Gas Analyzers
4.7 Venous Gas Analysers Trend:

5. North America Arterial Blood Gas Kits Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Incidence of Respiratory Diseases
- 5.1.2 Rising Number of Admissions to Emergency Units in Hospitals
5.2 Market Restraints
- 5.2.1 High Cost of Kits and Complications Associated with Arterial Blood Sampling
5.3 Market Opportunities
- 5.3.1 Surging Adoption of Point-of-Care Diagnostics in Emerging Countries
5.4 Future Trends
- 5.4.1 Development of Safe & Automated Kits and Integration of Electronic Medical Records
5.5 Impact of Drivers and Restraints:

6. Arterial Blood Gas Kits Market - North America Analysis

6.1 North America Arterial Blood Gas Kits Market Overview
6.2 Arterial Blood Gas Kits Market Revenue (US$ Thousand), 2021-2031
6.3 North America Arterial Blood Gas Kits Market Forecast Analysis

7. North America Arterial Blood Gas Kits Market Analysis - by Syringe Type

7.1 Luer Slip Syringe
- 7.1.1 Overview
- 7.1.2 Luer Slip Syringe: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
7.2 Luer Lock Syringe
- 7.2.1 Overview
- 7.2.2 Luer Lock Syringe: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)

8. North America Arterial Blood Gas Kits Market Analysis - by Type

8.1 Vented
- 8.1.1 Overview
- 8.1.2 Vented: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
8.2 Non-vented
- 8.2.1 Overview
- 8.2.2 Non-vented: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)

9. North America Arterial Blood Gas Kits Market Analysis - by Usage

9.1 Pre-set Plunger Mode
- 9.1.1 Overview
- 9.1.2 Pre-set Plunger Mode: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
9.2 Manual Aspiration
- 9.2.1 Overview
- 9.2.2 Manual Aspiration: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)

10. North America Arterial Blood Gas Kits Market Analysis - by Application

10.1 In Vitro Diagnostics
- 10.1.1 Overview
- 10.1.2 In Vitro Diagnostics: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
10.2 Electrolyte Analysis
- 10.2.1 Overview
- 10.2.2 Electrolyte Analysis: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)

11. North America Arterial Blood Gas Kits Market Analysis - by Needle Gauge

11.1 Less Than 23G
- 11.1.1 Overview
- 11.1.2 Less Than 23G: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
11.2 23G to 25G
- 11.2.1 Overview
- 11.2.2 23G to 25G: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
11.3 Greater Than 25G
- 11.3.1 Overview
- 11.3.2 Greater Than 25G: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)

12. North America Arterial Blood Gas Kits Market Analysis - by Syringe Volume

12.1 1 ml
- 12.1.1 Overview
- 12.1.2 1 ml: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
12.2 3 ml
- 12.2.1 Overview
- 12.2.2 3 ml: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
12.3 Others
- 12.3.1 Overview
- 12.3.2 Others: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)

13. North America Arterial Blood Gas Kits Market Analysis - by End User

13.1 Hospitals & Clinics
- 13.1.1 Overview
- 13.1.2 Hospitals & Clinics: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
13.2 Diagnostic Laboratories
- 13.2.1 Overview
- 13.2.2 Diagnostic Laboratories: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
13.3 Others
- 13.3.1 Overview
- 13.3.2 Others: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)

14. North America Arterial Blood Gas Kits Market - Country Analysis

14.1 North America Market Overview
- 14.1.1 North America: Arterial Blood Gas Kits Market Breakdown, by Key Country, 2023 and 2031 (%)
  - 14.1.1.1 North America: Arterial Blood Gas Kits Market - Revenue and Forecast Analysis - by Country
  - 14.1.1.2 United States: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 14.1.1.2.1 United States: Arterial Blood Gas Kits Market Breakdown, by Syringe Type
    - 14.1.1.2.2 United States: Arterial Blood Gas Kits Market Breakdown, by Type
    - 14.1.1.2.3 United States: Arterial Blood Gas Kits Market Breakdown, by Usage
    - 14.1.1.2.4 United States: Arterial Blood Gas Kits Market Breakdown, by Application
      - 14.1.1.2.4.1 United States: Arterial Blood Gas Kits Market Breakdown, by In Vitro Diagnostics
    - 14.1.1.2.5 United States: Arterial Blood Gas Kits Market Breakdown, by Needle Gauge
    - 14.1.1.2.6 United States: Arterial Blood Gas Kits Market Breakdown, by Syringe Volume
      - 14.1.1.2.6.1 United States: Arterial Blood Gas Kits Market Breakdown, by 1 ml
      - 14.1.1.2.6.2 United States: Arterial Blood Gas Kits Market Breakdown, by 3 ml
    - 14.1.1.2.7 United States: Arterial Blood Gas Kits Market Breakdown, by End User
  - 14.1.1.3 Canada: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 14.1.1.3.1 Canada: Arterial Blood Gas Kits Market Breakdown, by Syringe Type
    - 14.1.1.3.2 Canada: Arterial Blood Gas Kits Market Breakdown, by Type
    - 14.1.1.3.3 Canada: Arterial Blood Gas Kits Market Breakdown, by Usage
    - 14.1.1.3.4 Canada: Arterial Blood Gas Kits Market Breakdown, by Application
      - 14.1.1.3.4.1 Canada: Arterial Blood Gas Kits Market Breakdown, by In Vitro Diagnostics
    - 14.1.1.3.5 Canada: Arterial Blood Gas Kits Market Breakdown, by Needle Gauge
    - 14.1.1.3.6 Canada: Arterial Blood Gas Kits Market Breakdown, by Syringe Volume
      - 14.1.1.3.6.1 Canada: Arterial Blood Gas Kits Market Breakdown, by 1 ml
      - 14.1.1.3.6.2 Canada: Arterial Blood Gas Kits Market Breakdown, by 3 ml
    - 14.1.1.3.7 Canada: Arterial Blood Gas Kits Market Breakdown, by End User
  - 14.1.1.4 Mexico: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 14.1.1.4.1 Mexico: Arterial Blood Gas Kits Market Breakdown, by Syringe Type
    - 14.1.1.4.2 Mexico: Arterial Blood Gas Kits Market Breakdown, by Type
    - 14.1.1.4.3 Mexico: Arterial Blood Gas Kits Market Breakdown, by Usage
    - 14.1.1.4.4 Mexico: Arterial Blood Gas Kits Market Breakdown, by Application
      - 14.1.1.4.4.1 Mexico: Arterial Blood Gas Kits Market Breakdown, by In Vitro Diagnostics
    - 14.1.1.4.5 Mexico: Arterial Blood Gas Kits Market Breakdown, by Needle Gauge
    - 14.1.1.4.6 Mexico: Arterial Blood Gas Kits Market Breakdown, by Syringe Volume
      - 14.1.1.4.6.1 Mexico: Arterial Blood Gas Kits Market Breakdown, by 1 ml
      - 14.1.1.4.6.2 Mexico: Arterial Blood Gas Kits Market Breakdown, by 3 ml
    - 14.1.1.4.7 Mexico: Arterial Blood Gas Kits Market Breakdown, by End User

15. Competitive Landscape

15.1 Arterial Blood Gas Kits Market, Company Share Analysis - 2023
15.2 Blood Gas Analyzers Market, Company Share Analysis - 2023
- 15.2.1 Overview

16. Industry Landscape

16.1 Overview
16.2 Growth Strategies in Arterial Blood Gas Kits Market
16.3 Organic Growth Strategies
- 16.3.1 Overview
16.4 Inorganic Growth Strategies
- 16.4.1 Overview

17. Company Profiles

17.1 Radiometer Medical ApS
- 17.1.1 Key Facts
- 17.1.2 Business Description
- 17.1.3 Products and Services
- 17.1.4 Financial Overview
- 17.1.5 SWOT Analysis
- 17.1.6 Key Developments
17.2 Vyaire Medical Inc
- 17.2.1 Key Facts
- 17.2.2 Business Description
- 17.2.3 Products and Services
- 17.2.4 Financial Overview
- 17.2.5 SWOT Analysis
- 17.2.6 Key Developments
17.3 Opti Medical Systems
- 17.3.1 Key Facts
- 17.3.2 Business Description
- 17.3.3 Products and Services
- 17.3.4 SWOT Analysis
- 17.3.5 Key Developments
17.4 Siemens Healthineers AG
- 17.4.1 Key Facts
- 17.4.2 Business Description
- 17.4.3 Products and Services
- 17.4.4 Financial Overview
- 17.4.5 SWOT Analysis
- 17.4.6 Key Developments
17.5 AdvaCare Pharma USA LLC
- 17.5.1 Key Facts
- 17.5.2 Business Description
- 17.5.3 Products and Services
- 17.5.4 Financial Overview
- 17.5.5 SWOT Analysis
- 17.5.6 Key Developments
17.6 Becton Dickinson and Co
- 17.6.1 Key Facts
- 17.6.2 Business Description
- 17.6.3 Products and Services
- 17.6.4 Financial Overview
- 17.6.5 SWOT Analysis
- 17.6.6 Key Developments
17.7 ICU Medical Inc
- 17.7.1 Key Facts
- 17.7.2 Business Description
- 17.7.3 Products and Services
- 17.7.4 Financial Overview
- 17.7.5 SWOT Analysis
- 17.7.6 Key Developments
17.8 SunMed Group Holdings LLC (AirLife)
- 17.8.1 Key Facts
- 17.8.2 Business Description
- 17.8.3 Products and Services
- 17.8.4 Financial Overview
- 17.8.5 SWOT Analysis
- 17.8.6 Key Developments
17.9 Trudell Healthcare Solutions Inc
- 17.9.1 Key Facts
- 17.9.2 Business Description
- 17.9.3 Products and Services
- 17.9.4 Financial Overview
- 17.9.5 SWOT Analysis
- 17.9.6 Key Developments
17.10 SARSTEDT AG & Co KG
- 17.10.1 Key Facts
- 17.10.2 Business Description
- 17.10.3 Products and Services
- 17.10.4 Financial Overview
- 17.10.5 SWOT Analysis
- 17.10.6 Key Developments
17.11 Lepu Medical Technology Beijing Co Ltd
- 17.11.1 Key Facts
- 17.11.2 Business Description
- 17.11.3 Products and Services
- 17.11.4 Financial Overview
- 17.11.5 SWOT Analysis
- 17.11.6 Key Developments

18. Appendix

18.1 About The Insight Partners